Our equity story
Find out more
Roche invests for the future in its Basel site
Roche delivers solid sales growth for the first nine months of 2014
FDA approves Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF) in the United States
All Investor Updates
Get up-to-date information about our Pharma and Diagnostics pipeline.
The Roche Finance Information System lets access and download key financial data easily.
Watch the video.
October 16, 2014, Basel, Switzerland3rd Quarter 2014 Conference Call
Find out more about Roche and sustainability.
Please call the Roche switchboard onPhone: +41 61 688 11 11
Email IR TeamPhone: +41 61 688 8880Fax: +41 61 691 0014
Please call the Genentech switchboard onPhone: +1 650 225 1000
Email IR TeamPhone: +1 650 225 5566Fax: +1 650 225 8326
More contact options
You are here: